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The Involvement of Voltage-Operated Calcium Channels
in Somato-Dendritic Oxytocin Release
Vicky A. Tobin, Alison J. Douglas, Gareth Leng, Mike Ludwig*
Centre for Integrative Physiology, University of Edinburgh, Edinburgh, United Kingdom
Abstract
Magnocellular neurons of the supraoptic nucleus (SON) secrete oxytocin and vasopressin from axon terminals in the
neurohypophysis, but they also release large amounts of peptide from their somata and dendrites, and this can be
regulated both by activity-dependent Ca2+ influx and by mobilization of intracellular Ca2+. This somato-dendritic release can
also be primed by agents that mobilise intracellular Ca2+, meaning that the extent to which it is activity-dependent, is
physiologically labile. We investigated the role of different Ca2+ channels in somato-dendritic release; blocking N-type
channels reduced depolarisation-induced oxytocin release from SONs in vitro from adult and post-natal day 8 (PND-8) rats,
blocking L-type only had effect in PND-8 rats, while blocking other channel types had no significant effect. When oxytocin
release was primed by prior exposure to thapsigargin, both N- and L-type channel blockers reduced release, while P/Q and
R-type blockers were ineffective. Using confocal microscopy, we found immunoreactivity for Cav1.2 and 1.3 channel
subunits (which both form L-type channels), 2.1 (P/Q type), 2.2 (N-type) and 2.3 (R-type) in the somata and dendrites of both
oxytocin and vasopressin neurons, and the intensity of the immunofluorescence signal for different subunits differed
between PND-8, adult and lactating rats. Using patch-clamp electrophysiology, the N-type Ca2+ current density increased
after thapsigargin treatment, but did not alter the voltage sensitivity of the channel. These results suggest that the
expression, location or availability of N-type Ca2+ channels is altered when required for high rates of somato-dendritic
peptide release.
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Introduction
Many neurons release a wide variety of signalling molecules
from their soma and dendrites to autoregulate their activity,
communicate with adjacent neurons and glia, and modulate
afferent nerve ending activity [1–4].
In magnocellular neurons of the supraoptic (SON) and
paraventricular nuclei, oxytocin and vasopressin are released from
somata and dendrites, with important consequences [5,6]. In
particular, somato-dendritic oxytocin release plays an essential role
in the milk-ejection reflex, co-ordinating the intermittent synchro-
nous activation of oxytocin neurons that underlies pulsatile
oxytocin secretion [7,8]. Somato-dendritic oxytocin and vasopres-
sin release is also prominent during early postnatal development,
when it is important for the modelling of dendritic morphology
[9].
Like the release of conventional neurotransmitters, oxytocin and
vasopressin secretion from axon terminals in the neurohypophysis
depends on depolarisation-evoked Ca2+ entry through high-
voltage-activated Ca2+ channels. N-, P/Q- and (in vasopressin
neurons only) R-type channels regulate action-potential dependent
secretion from the terminals, while L- channels are present at the
terminals but play little role in this [10]. Similarly, at most
synapses in the CNS neurotransmitter release is governed by N
and/or P/Q type channels [11,12]. Somato-dendritic release of
oxytocin and vasopressin also depends on the entry of extracellular
Ca2+ [13,14] and L-, P/Q-, N- and R-type channels are expressed
on the somata and dendrites of magnocellular neurones [15–19].
Dendritic release of oxytocin and vasopressin can also be
evoked by agents that mobilise intracellular Ca2+ stores, and this
can occur independently of electrical activity, and hence
independently of secretion from the neurohypophysis [20,21].
Dendritic release can also be evoked by electrical activity, but for
this to occur in vivo, the neurons must first be ‘‘primed’’. Priming
involves a long-lasting increase in the releasability of vesicles in
the soma and dendrites (no priming occur in the axon terminals)
[20,22], and is thought to involve translocation of vesicles to
release sites at the plasma membrane [23] adjacent to voltage-
gated Ca2+ channels.
Dendritic oxytocin and vasopressin release can be primed in vitro
by exposing the isolated SON to mobilisation of intracellular Ca2+
by thapsigargin or cyclopiazonic acid, and is seen as a late
emerging and prolonged potentiation of depolarisation evoked
peptide release [20,22]. We hypothesised that this might be
achieved in part by a change in Ca2+ entry via voltage operated
Ca2+ channels.
High-voltage activated Ca2+ channels have an a1-subunit,
which forms the Ca2+-selective membrane pore, and auxiliary
subunits which modulate channel properties such as inactivation
and channel targeting; CaV1.2 and 1.3 form L-type channels and
CaV2.1, 2.2 and 2.3 form P/Q-, N- and R-type channels
respectively [24].
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Here we used selective Ca2+ channel blockers to identify their
contributions to depolarisation-induced oxytocin release and to
whole-cell Ca2+ currents. We have also used fluorescence
immunocytochemistry to describe the a1-subunits distribution in
oxytocin and vasopressin neurons and to determine changes in
subunit expression at times of high dendritic release (lactation and
postnatal day 8 (PND-8)) and after thapsigargin-induced priming.
Results
Involvement of different Ca2+ channels in somato-
dendritic peptide release
Explants of the SON responded to two repeated depolarisations
(S1 and S2: 50 mM K+) with similar amounts of oxytocin release
(Fig. 1A,B; controls are shown in black lines). The Ca2+ channel
toxins were applied for 20 min, 10 min before and 10 min during
the S2 stimulation. The effects of Ca2+ channel toxins were
quantified as the release in response to S2 (in the presence of toxin)
expressed as a percentage of the response to S1. Each toxin was
tested in a separate set of experiments. The data for toxin and
vehicle experiments were analysed together (using an ANOVA
followed by Dunn’s post-hoc test) for experiments in adult rats, adult
rats treated with thapsigargin, and PND-8 rats.
The N-type channel blocker v-conotoxin GV1A reduced
stimulus-evoked oxytocin release from the SON of both adult
and PND-8 rats (Fig. 1A,B; S2:S1, 5068% and 6765%
respectively, P,0.05), while treatment with the vehicle control
(0.1% DMSO) had no significant effect (adult and PND-8 S2:S1
Figure 1. Effects of VOCC toxins on oxytocin release from SONs in vitro. Blocking N-type VOCC in SONs from adult (A) PDN-8 (B),
thapsigargin- (TG)-treated adult rats (C) and TG-treated PDN-8 rats (D) shows a decrease in amplitude and duration of the potassium stimulated
response. Stimulated release was enhanced after pretreatment with 0.2 mM TG as previously described (C D black lines) (Ludwig et al., 2002); this was
prevented by blocking N-type Ca2+ channels (red lines). Effects of blocking different VOCC on the S2:S1 oxytocin response in SONs from adult and
adult TG-treated rats (E) and PND-8 rats and TG-treated PDN-8 rats (F). Means6S.E.M., n=6 per group, # P,0.05 vs first S1, * P,0.05 vs control, one-
way ANOVA followed by Dunn’s post-hoc test.
doi:10.1371/journal.pone.0025366.g001
VOCCs and Dendritic Peptide Release
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10164% and 105611; Fig. 1A,E and Fig. 1B,F). The L-type
blocker nicardipine also reduced release from the SON in PND-8
rats (S2:S1, 6663%, P,0.05) but not significantly in adult rats
(S2:S1, 80610%, N.S.). P/Q- and R-type blockers had no
significant effect on release in any group (Fig. 1B–D).
In SON neurons, thapsigargin induces an increase in intracel-
lular [Ca2+] lasting ,10 min [25] accompanied by an immediate
but small increase in somato-dendritic oxytocin and vasopressin
release; in addition, thapsigargin provokes a persistent change in
the releasability of peptides from the somata and dendrites
(priming). This is apparent as significantly increased peptide release
in response to a later depolarising stimulus; it emerges at least
15 min after thapsigargin treatment and lasts for at least 90 min
[20]. We tested whether this priming might, in part, reflect a
change in Ca2+ entry via voltage-activated Ca2+ channels.
Confirming previous studies [20], pre-exposure of adult rat
SONs to thapsigargin for 10 min produced a marked enhance-
ment of oxytocin release evoked by a subsequent depolarisation
(applied 30 min after thapsigargin; Fig. 1C, black line; Fig. 1E,
S2:S1, 386650%; P,0.05, t test vs vehicle controls). Thapsigargin
treatment also primed oxytocin release in SONs from PND-8 rats
(Fig. 1D black line; Fig. 1F S2:S1 248623%; P,0.05, t-test vs
vehicle controls). This primed response was reduced in the
presence of the N-type blocker in SONs from both adult and
PND-8 rats (S2:S1: 11765% and 77617% respectively; Fig. 1C,D
red lines; Fig. 1E,F; P,0.05 ANOVA). The primed response was
also reduced (though to a lesser extent) by the L-type blocker
nicardipine (adult and PND-8 S2:S1: 199%613% and 135622,
P,0.05, ANOVA, Fig. 1E,F). P/Q- and R-type blockers had no
significant effect in SONs of adult rats with or without thapsigargin
pretreatment (Fig. 1E). There were also no significant effects of
blocking P/Q and R-type Ca2+ channels in PND-8 SONs (their
effects were not determined (ND) after TG treatment, Fig. 1F). As
highlighted in Figures 1A–D, the effect of N-type channel
blockade on depolarisation-induced oxytocin release in both
PND-8 and adult SONs with and without priming is a small
decrease in the amplitude of the response but a large decrease in
its duration.
Thus depolarisation-induced oxytocin release from adult rat
SONs depends on Ca2+ influx particularly via N-type channels,
and thapsigargin-induced priming may involve a change in the
activity and/or numbers of these channels.
Immunohistochemical characterisation of VOCC a1
subunits in SON sections
To examine changes in the expression of Cav subunits at times
of high secretory demand, we compared CaV a-subunit immuno-
reactivity in SON sections from PND-8 and lactating rats with
sections from adult rats. Specificity of Cav a-subunit immunore-
activity was assessed by pre-absorption controls. Each antibody
was pre-incubated with five-fold concentration of immunogen
used to raise the antibody (provided by Alomone) before being
applied to representative sections and this resulted in no
fluorescent signal (data not shown). In adult rats (Fig. 2A,B),
immunoreactivity for all five a1-subunits was present in the somata
and dendrites of both vasopressin and oxytocin neurons. To
compare signals between groups, the optical density of Cav
subunits were measured in oxytocin or vasopressin immunoreac-
tive regions of the SON. The optical density of subunits in these
regions showed age- and physiological state-dependent differences
(Fig. 2C,D). In areas of the SON defined by immunoreactivity for
either oxytocin or vasopressin, the signal for Cav1.2 was stronger
in PND-8 rats than in adult and lactating rats (P,0.05, ANOVA).
On the other hand, the Cav1.3 signal was weaker in oxytocin (but
not vasopressin) areas of PND-8 rats (P,0.05 vs adults, ANOVA),
and stronger in both oxytocin and vasopressin regions from
lactating rats (P,0.05 vs adults, ANOVA). The Cav2.2 signal was
not changed in vasopressin regions, but in oxytocin areas it was
stronger in PND-8 and during lactation (P,0.05 vs adults,
ANOVA).
Thus, during lactation, when central and peripheral oxytocin
release is increased, there is also an increased expression of Cav1.3
and 2.2, which define L and N-type channels respectively in
oxytocin-immunoreactive regions. In PND-8 rats, where there is
high dendritic secretion of both oxytocin and vasopressin, there is
higher expression of Cav1.2 (which also defines L-type channels) in
both oxytocin- and vasopressin-rich regions of the SON, and
higher expression of Cav2.2 in oxytocin-rich regions. These
changes include signal throughout the neuron somata and
dendrites both in the cytoplasm and at the plasma membrane.
Immunohistochemical characterisation of VOCC a1
subunits in single SON neurons
In other neuroendocrine cells there is evidence for co-
localisation of Ca2+ channel subtypes with secretory vesicles at
the plasma membrane [26]. We used fluorescence immunohisto-
chemistry and confocal microscopy to investigate associations of
Ca2+ channels and peptide-containing vesicles in acutely dissoci-
ated SON neurons (Fig. 3). Again, the specificity of the Cav a-
subunit antibodies was assessed by pre-incubating each antibody
with a five-fold (w/v) of the immunogen used to raise the antibody
(provided by antibody supplier–Alomone). In all cases, pre-
incubation of the antibody with the immunogen resulted in no
fluorescent signal (data not shown).
In oxytocin neurons, although a punctate oxytocin signal was
present in all cytoplasmic regions, the density was consistently
highest in the perinuclear region (Fig. 3A). In vasopressin neurons,
punctate immunoreactivity for vasopressin was present at a
relatively constant average density throughout the cytoplasm in
the soma and proximal dendrites (Fig. 3B).
Punctate immunoreactivity for all a1-subunits was present in
both oxytocin and vasopressin neurons in their somata and
proximal dendrites (Fig. 3A,B). In both cell types, the Cav1.3 and
2.1 subunits are evenly distributed throughout the cytoplasm,
whereas the signal for Cav2.2 was strongest in the perinuclear
region. Cav1.2 and 2.3 subunits were present throughout the
cytoplasm, but there was also a strong nuclear signal in both
oxytocin and vasopressin neurons.
We quantitatively analysed the colocalisation of each channel
subunit with oxytocin, vasopressin, and a Golgi marker. The
degree of colocalisation can be inferred by correlating the intensity
of the subunit signal with the oxytocin or vasopressin signal for
every voxel (scatterplots in Fig. 3A,B). The best fit line was then
used to calculate the Pearson’s coefficient of variation, which
ranges from 0.5 (random co-localisation) to 1.0 (perfect co-
localisation). The residual maps show the spatial distribution of the
Pearson’s coefficient of variation (i.e. where colocalisation is
strongest, represented in cyan and weakest, in red). For
colocalisation with oxytocin, the mean Pearson’ coefficient of
variation was highest for Cav2.2 (0.8860.02, n= 5, Fig. 3C), and
lowest for Cav2.3; the association of Cav2.3 with oxytocin
(0.5460.05) was close to that expected for random colocalisation.
The residual map for Cav2.3 and oxytocin shows that the nucleus
contains a relatively strong Cav2.3 signal and a weak or absent
oxytocin signal, while the subplasmalemal zone shows the
converse. For Cav2.2, the residual maps show some signal in the
nucleus, but in all other areas of the cell there was relatively strong
VOCCs and Dendritic Peptide Release
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colocalisation with oxytocin. For vasopressin there was no
significant difference in the Pearson’ coefficient of variation for
any of the subunits (Fig. 3C).
As Cav2.1 and 2.2 subunits consistently appeared to have a
strong perinuclear signal (Fig. 4A), we examined the association of
subunits with the Golgi marker (cis-Golgi matrix protein; GM130).
The Pearson’s co-efficient for Cav2.2 with GM130 was signifi-
cantly greater than that between the Golgi and all other subunits
(Fig. 4B, P,0.05).
Thus the subcellular distribution of Cav2.2, which defines N-type
channels, is similar to that of oxytocin immunoreactivity, with a
particularly strong signal at the Golgi apparatus where oxytocin is
Figure 2. Ca2+ channel distribution in tissue sections of SON. (A) Immunostaining for Cav subunits (red staining) and oxytocin (A) or
vasopressin (B) (green staining) in SON sections from PND-8, adult, and lactating rats. Average optical density for the subunits normalised by the
optical density of (C) oxytocin and (D) vasopressin (n = 5). No labelling was detected when primary antibodies were omitted or incubated with a five-
fold excess of control immunogen before being exposed to the tissues (not shown). Means6S.E.M. vs adult, # P,0.05 vs lactating rats, one-way
ANOVA followed by Holm-Sidak post-hoc test. Scale bars, 20 mm.
doi:10.1371/journal.pone.0025366.g002
VOCCs and Dendritic Peptide Release
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packaged into dense-cored vesicles. In vasopressin neurons there is a
much weaker colocalisation of Cav2.2 with vasopressin, as vasopressin
immunoreactivity is not as strongly expressed at the Golgi as oxytocin
immunoreactive signal. The results suggest that even if the N-type
channels are not expressed in the same vesicles as either peptide, that
there may be a common pathway or control of the intracellular
distribution and translocation of the N-type channels. Dense-cored
vesicles in oxytocin and vasopressin magnocellular neurons have
previously been demonstrated to be re-distributed towards the plasma
membrane following a priming stimulus [23].
Effect of priming on Ca2+ current densities
Changes in immunohistochemically identified a-subunits do not
necessarily represent changes in the related Ca2+ currents.
Therefore, we investigated changes in Ca2+ currents in isolated
magnocellular neurons from adult rats using specific Ca2+ channel
blockers before and after priming with thapsigargin.
Before being patched, neurons were treated with either vehicle
(DMSO 0.1%) or thapsigargin (0.2 mM) for 30 min and identified
as vasopressin or oxytocin cells by the presence or absence of an
eGFP signal, respectively (Fig. 5A). Whole-cell calcium currents
(WCCC) were evoked by voltage steps from 260 to +30 mV (in
10 mV increments) over 250 ms. The results showed that the
current-voltage relationship was not different between oxytocin
and vasopressin cells and thus data were pooled for analysis
(Fig. 5B). These currents were normalised against the peak
maximum current evoked by a depolarisation to 210 mV. These
were used to express the mean normalised conductance (G/Gmax)
at each potential. The data points were fitted using the following
Boltzmann equation (see Methods, Fig. 5C).
V0.5 (which represents the half-maximal activation) and k (which
represents the conductance slope) for WCCC, N-, and L-type
Ca2+ currents were each compared with and without TG
treatment and showed no significant difference (Fig. 5C). Thus
Figure 3. Ca2+ channel distribution in isolated magnocellular neurons. Immunostaining for Cav a1 subunits (red) in acutely-dispersed
oxytocin (A) and vasopressin neurons (B) (green). Immunostaining for all subunits was observed in the soma and dendrites, in both in the cytoplasm
and at the plasma membrane. Immunostaining for oxytocin and Cav2.1 and 2.2 also showed strong perinuclear staining. The merged images show
areas of coincidence in yellow (third column). Scatter plots (fourth column) show co-variance of subunit signal with the oxytocin signal for each voxel
The residual map corresponds to weighted residuals from the line fit to the scatter plot, thus indicating fluorescent channel covariance (hue from –1
to 1, with cyan corresponding to zero residual). (C) Quantification of covariance data of oxytocin or vasopressin and one of the five a1-subunits using
Pearson’s coefficient values (n = 5 per group). Means6S.E.M. * P,0.05, one-way ANOVA followed by Holm-Sidak post-hoc test vs Cav2.2. Scale bars
10 mm.
doi:10.1371/journal.pone.0025366.g003
VOCCs and Dendritic Peptide Release
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TG treatment does not affect the activation kinetics for WCCC,
N-, and L-type Ca2+ currents.
In addition, voltage-dependent currents were evoked by a
voltage step from -60 mV to 0 mV for 250 ms, repeated three
times every 5 min (Fig. 5E). The current amplitude in the last
10 ms of the step (steady-state current) was measured from the
average current evoked from the three voltage steps. Steady-state
current was measured before and after sequential applications of
the channel blockers (1 mM nicardipine, 0.2 mM v-agatoxin IVA,
0.5 mM v-conotoxin GVIA and 0.02 mM SNX 482 or vehicle
(0.1% DMSO). Once started, each Ca2+ channel blocker was
continuously applied until the end of recording to ensure no effect
of toxin wash-out. The amplitude of current carried by each
channel was calculated as the difference between the amplitude of
the current after the specific Ca2+ channel toxin treatment and the
current before treatment (Fig. 5D). In five cells currents measured
using the voltage-step protocol repeated three times every 5 min
for 45 min without application of toxins showed no change in
amplitude, indicating no run down in Ca2+ currents (dada not
shown).
Acutely dissociated magnocellular neurons retain different
lengths of dendrites and thus have different whole-cell Ca2+
currents, so we normalised Ca2+ currents by the capacitance
measured for that cell, giving current densities (pA/pF). Initially
we did not determine whether cells were oxytocin or vasopressin
neurons, but both show thapsigargin-induced priming [20,22].
The current densities of each channel type were averaged (Fig. 5F)
and the effect of thapsigargin pretreatment on the inferred
amplitude of current carried by each channel type was compared
by unpaired t-test. In five control cells, the N-type channel blocker
v-conotoxin GVIA had the least effect on voltage-gated Ca2+
entry, while the L-type channel blocker nicardipine had the
greatest effect (Fig. 5D, black circles). In five cells pre-treated with
thapsigargin (0.2 mM for 10 min; 30–50 min before measurement
of current densities), v-conotoxin GVIA had a greater effect than
in control cells (Fig. 5F, grey bars, P,0.05 vs control), with no
significant differences in the effects of P/Q and L-type channel
blockers. There was no significant difference in the average
WCCC amplitude between control cells and thapsigargin-treated
cells.
In an additional experiment, using identified vasopressin and
oxytocin cells, again we found no significant difference in the
WCCC. The L- and N-type channel toxins were applied in
alternating order to exclude an effect of treatment order. As there
was no effect of treatment order and no difference between cell
types, the results were pooled. The results confirmed that, after
TG treatment there was a significant increase in N-type Ca2+
current density, but no significant change in WCCC and the L-
type current density (Fig. 5G).
Overall these results show that TG treatment results in an
increase in Ca2+ current carried by the N-type Ca2+ channel. The
lack of effect on channel activation kinetics suggests that TG
treatment increases the number of N-type channels.
Discussion
In the present study, we found that in vitro depolarisation-
induced oxytocin secretion from adult SONs depends on Ca2+
influx particularly via N-type channels. As reported previously (and
replicated in the present experiments), mobilisation of intracellular
Ca2+ by thapsigargin results in a prolonged enhancement
(‘priming’) of depolarisation-induced peptide release, and this is
particularly marked for oxytocin [20]. We have previously shown
that priming involves a reorganisation of the F-actin cytoskeletal
network and translocation of peptide-containing vesicles to close to
the plasma membrane [21,27]. Priming is potentially an important
general mechanism of neuronal plasticity; in the oxytocin system,
priming has been proposed to underlie the functional reorganisa-
tion of the oxytocin system in lactating rats in response to suckling,
giving rise to the ability of this system to generate synchronised
bursts of electrical activity leading to the pulsatile oxytocin
secretion that is essential for efficient milk let-down [8,20]. Here,
we found that thapsigargin-induced priming was accompanied by
a significant increase in both the Ca2+ current carried by N-type
channels and the extent to which depolarisation-evoked dendritic
release depends on these channels.
We saw some contribution of L-type channels to evoked release
in both control and thapsigargin-primed conditions in adult and
PDN-8 rats, but no evidence of a significant contribution from P/
Figure 4. Ca2+ channel distribution in relation to the Golgi
apparatus. (A) Immunostaining for Cav a1 subunits (red) and the
Golgi marker GM130 (green) in acutely-dispersed supraoptic neurons.
There was strong co-localisation of Cav2.2 with GM130, a marker for
the Golgi apparatus. No fluorescent labelling was detected when
primary antibodies were omitted or incubated with a five-fold excess
of control immunogen before being exposed to the cells (not shown).
(C) Quantification of covariance data of GM130 and one of the five a1-
subunits using Pearson’s coefficient values (n = 5 per group) showed a
significant difference between the co-localisation of GM130 and Cav2.2
versus the other a1-subunits. Means6S.E.M. * P,0.05, one-way
ANOVA followed by Holm-Sidak post-hoc test vs Cav2.2. Scale bars
10 mm.
doi:10.1371/journal.pone.0025366.g004
VOCCs and Dendritic Peptide Release
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Figure 5. Effects of channel toxins on Ca2+ currents in isolated SON neurons. (A) Isolated magnocellular neurons were identified as either
vasopressin or oxytocin by their presence or absence of the GFP signal. Scale bar = 10 mm. (B) The current-voltage relationships show no difference
between whole-cell calcium currents (WCCC) of vasopressin and oxytocin neurons (n = 20 each). (C) Normalized conductance (G/Gmax, fitted using
Boltzmann equation) showed no significant change with or without TG. (D) Examples of two neurons (both oxytocin neurons), one vehicle treated (N)
and one 50 min after pre-treating with thapsigargin (#). The steady-state Ca2+ current is plotted against time following treatment with channel
toxins (in order: 1 mM nicardipine; 200 nM v-agatoxin IV; 500 nM v-conotoxin GVIA). The current measured after each toxin was subtracted from that
evoked before each treatment to determine the current carried by L-, P/Q- and N-type channels. The remaining current was attributed to R-type
channels. (E) Examples of N-, L- and WCCC elicited by voltage steps in controls and TG treated cells. (F) The resulting current density for each current
type normalised for the peak maximal current was averaged (n = 5) to give the average current density from neurons treated with vehicle or
VOCCs and Dendritic Peptide Release
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Q- or R-type channels, although at the concentrations used all of
the blockers had at least as great an effect as the N-type channel
blocker v-conotoxin GVIA on voltage-gated Ca2+ current.
However, it should be noted that in these experiments we used
high K+ as a depolarising stimulus, and in the neurohypophysis the
contribution of L-type channels to secretion evoked by high K+ is
greater than to secretion evoked by action potentials.
Previous studies have shown expression of L-, P/Q-, N- and R-
type channels in both the somata-dendrites [10,19] and nerve
terminals of magnocellular neurones [15,17,28–30]. Thus, all of
the Ca2+ channels that are expressed at the axon terminals are also
expressed at the cell bodies, but with different biophysical
properties; in particular, the N channels in the terminals inactivate
rapidly [28], whereas those in the soma are slowly or non-
inactivating [17].
In synapses in the CNS, the sites of neurotransmitter release are
defined by active zones containing clusters of Ca2+ channels [31].
Localised zones of Ca2+ entry have been identified in dendritic
spines of hippocampal CA3 neurons [32,33], but there is no
functional or morphological evidence for active zones in the soma,
dendrites or axon terminals of vasopressin and oxytocin cells [34].
Indeed, in magnocellular neurons, exocytosis can apparently occur
at any site on the cell surface–including even from undilated axons;
from electron-microscopy studies it appears that the proportion of
release observed from any of the compartments of magnocellular
neurons (soma, dendrite, undilated axons, axonal swellings and
nerve endings) simply reflects the number of vesicles in that
compartment that are close to the cell membrane. If this is the
case, how is it that exocytosis (from nerve terminals or dendrites) is
so dependent on N-type channels, when this subtype is responsible
for less voltage-gated Ca2+ entry than other subtypes? The likely
answer is that, in magnocellular neurons as in other CNS neurons,
N-type channels are strongly clustered at sites on the cell
membrane, that at these sites there is a large but highly localised
Ca2+ entry, and as a result these clusters define sites of exocytosis,
but in magnocellular neurons these clusters are not localised to
synapses, and occur in all parts of the neuron.
Different CaV subtypes show different subcellular distributions
in neurons; CaV2.1 and CaV2.2 are mainly localised in axons and
at synapses, while CaV1 is mainly present in the soma and
dendrites. Cytoskeletal elements are involved in the localisation of
CaV to the plasma membrane [35–38]. In chromaffin cells, CaV2
channels are inserted into the plasma membrane as part of the
process of transforming growth cones into mature neurosecretory
endings [39,40]. In neuroblastoma cells, CaV2.2 channels are held
in a large reservoir of secretory granules at the Golgi and can be
recruited to the plasma membrane during regulated secretion [41].
Recruitment of Ca2+ channels from internal stores to the plasma
membrane has also been reported in bag cell neurons of Aplysia
californica [42–44]. In hippocampal neurons, during long term
potentiation, different Ca2+ channels (in particular CaV2.2) are
recruited to the plasma membrane to enhance neurotransmitter
release, at specific synapses [45].
The sub-cellular distribution of Cav2.2 was very similar to that
of oxytocin, with a particularly strong signal at the Golgi apparatus
where oxytocin is packaged into dense-cored vesicles. We also
found an increased expression of Cav2.2 in lactation, when there is
a high demand for dendritic oxytocin release, and in PND-8 rats,
where there is high dendritic secretion of both oxytocin and
vasopressin. Cav2.2, which defines N-type channels, might be co-
packaged in peptide-containing vesicles, as suggested by one
electron-microscopy study of the neurohypophysis [46]. Alterna-
tively, separate vesicles containing Cav2.2 may be tethered or
transported by the same cytoskeletal and molecular motors as used
by peptide-containing vesicles, as suggested by another electron
microscopy study [47].
The results presented in this paper do not allow us to definitively
state that N-type calcium channels are similarly re-distributed to
the plasma membrane after thapsigargin treatment. However, we
found the calcium current carried by N-type channels to be
increased after thapsigargin. This could be due to an increase in
numbers of channels at the membrane (by either increased
synthesis or translocation of existing channels to the plasma
membrane). The time between thapsigargin treatment and the
measurement of increased calcium current carried by the N-type
calcium channels argues against de novo synthesis of N-type
calcium channels and we found the CaV 2.2 subunit to be strongly
co-localised with a Golgi marker, unlike other CaV a1 subunits,
suggesting a reserve pool of CaV2.2 subunit. Or the increase could
be due to an increased activity of existing N-type channels
meaning greater calcium conductance per channel. We have
examined this possibility by conducting additional experiments,
comparing the kinetics of the calcium currents carried by N-type
calcium channels (the activation-voltage relationships), suggesting
that thapsigargin treatment resulted in an increase in N-type
channels at the plasma membrane. Thus, we hypothesis that a
reserve pool of N-type Ca2+ channels may be recruited to the
plasma membrane in response to the priming signal to increase
activity-dependent peptide release.
In conclusion, in magnocellular neurons, N-type channels
appear to be more functionally associated with somato-dendritic
secretion than other Ca2+channels, as blocking N-type channels
was most effective in inhibiting high K+-induced oxytocin
secretion both before and after priming, and priming exclusively
increased Ca2+ influx via N-type channels. Changes in N-type
channel availability at the plasma membrane may be crucial in
translating a change in action potential firing to somato-dendritic
peptide release.
Materials and Methods
Animals
Female Sprague-Dawley and Sprague-Wistar rats homozygous
for an enhanced green fluorescent protein–vasopressin fusion gene
(eGFP-vasopressin) [48] rats were housed under controlled
conditions with 12:12 h light dark cycle (lights on at 0700 h) with
food and water available ad libitum.
Ethics Statement
All procedures were approved by the UK Home Office under
the Animals (Scientific Procedures) Act 1986, under a project
licence approved by the local ethics committee.
Isolated SON
Adult randomly cycling female rats or PND-8 rats were
decapitated, their brains were rapidly removed and SONs
dissected out in normal Locke’s buffer (NL; composition in mM:
NaCl 140, KCl 5, 4-(2-hydroxyethyl)piperazine-1-ethanesulfonic
thapsigargin. (G) In a subsequent experiment L- or N-type channel toxins were administered, alternating the order (n = 5 for each condition).
Mean6S.E.M are shown and compared by t-test. *P,0.05 vs control.
doi:10.1371/journal.pone.0025366.g005
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acid (HEPES) 10, glucose 10, MgCl 1.2, CaCl2 2.2; pH 7.35,
osmolarity between 295 and 300 mOsm). Four SONs were placed
in a chamber containing 110 ml buffer, maintained at 35uC. The
buffer was replaced every 5 min for 45 min while secretion
reached equilibrium, after this, samples were taken every 5 min
and stored (220uC) for subsequent assay of peptide content. At
30 min after starting the experiment, SONs were stimulated with
50 mM K+ for 10 min (mM: NaCl 95, KCl 50, HEPES 10,
glucose 10, MgCl 1.2, CaCl2 2.2; pH 7.35, osmolarity between
295 and 300 mOsm). After 30 min, the tissue was treated either
with 0.2 mM thapsigargin or vehicle (0.1% DMSO) for 10 min.
Then, 60 min later, the tissue was treated with a Ca2+ channel
blocker or vehicle (0.1% DMSO) for 10 min followed by 50 mM
K+ plus the channel blocker or vehicle for 10 min. The channel
blockers used were: L-type, 1 mM nicardipine (Sigma-Aldrich,
UK); P/Q-type, 0.2 mM v-agatoxin IVA (Alomone Labs,
Jerusalem, Israel); N-type, 0.5 mM v-conotoxin GVIA (Alomone
Labs, Jerusalem, Israel); R-type, 0.02 mM SNX 482 (Alomone
Labs, Jerusalem, Israel).
Measurement of oxytocin
Oxytocin release was measured by radioimmunoassay as
previously described [49] using an antibody (oxytocin 242) kindly
provided by Chris Chapman (Babraham Institute, Cambridge,
UK). The oxytocin standard was obtained from the National
Institute for Biological Standards and Control (Potters Bar,
Hertfordshire, UK) and iodinated oxytocin from PerkinElmer
LAS Ltd (Beaconsfield, Bucks, UK). The assay had a sensitivity of
0.5 pg, inter-assay variability of 9% and intra-assay variability of
10%. Evoked oxytocin release was calculated by subtracting the
total basal release in the five fractions before stimulus from that
observed during (two fractions) and directly after (three fractions)
the K+ stimulus. The effect of channel blockers on the release
induced by a second K+ stimulus was calculated as the percentage
of the response to the first.
Dissociated SON neuron preparation
Adult female or eGFP-vasopressin rats were decapitated; the
SONs rapidly dissected in NL and incubated in oxygenated NL
containing 0.5 mg/ml deoxyribonuclease-1 and 1 mg/ml protease
X for 20 min at room temperature which was then replaced with
NL containing 0.5 mg/ml deoxyribonuclease-1 and 1 mg/ml
protease XIV for 20 min. The tissue was then incubated in
oxygenated NL for at least 60 min before further manipulation.
Single magnocellular neuron suspensions were generated by
mechanical tituration. The cell suspension was placed on poly-L-
lysine treated coverslips and cells allowed to adhere for 20–30 min
before in vitro electrophysiology. For immunohistochemistry, cells
were fixed in situ with 4% paraformaldehyde for 20 min at room
temperature.
Brain sections
Free-floating brain sections were from female adult random-
cycling, lactating rats or PND-8 pups which had been deeply
anaesthetised (Sagatal, 1 ml i.p.) then perfused through the
ascending aorta with heparin (5000 U/ml; 300 ml in 0.9% NaCl
solution) followed by 300 ml of 4% paraformaldehyde in 0.1 M
phosphate buffer (PB, pH 7.4). The brains were removed and
immersed overnight in a solution of 0.2% paraformaldehyde and
15% sucrose in 0.1 M PB at 4uC. The tissue was then placed in
30% sucrose in 0.1 M PB and left at 4uC until it had sunk (48 h).
The hypothalami were cut coronally with a freezing microtome
(40 mm) and rinsed in 0.1 M PB before fluorescence immunocy-
tochemistry.
Fluorescence Immunocytochemistry
Sections containing the SON from three rats in each group
(adult, lactating and PND-8) were distributed so at least one
section per rat in each treatment group was exposed to each
different antibody combination. In this way, at least 5 SON from 3
different rats were used to analyse each different combination of
peptide and one of the five Cav a1-subunit isoforms. Fixed
dissociated neurons were washed with 0.1 M PB and processed in
situ in multi-well trays.
After washing, sections or dissociated neurons were incubated
for 30 min in a blocking buffer consisting of 1% BSA + 0.2%
Triton X-100 in 0.1 M PB. They were then incubated with
primary antibodies against oxytocin, vasopressin (PS38 and PS41
respectively, a kind gift from Dr Hal Gainer) or the Golgi marker
GM130 (1/500, BD Transduction Laboratories, only data for
dissociated neurons shown) and one of five Cav a1-subunit
isoforms: 1.2, 1.3, 2.1, 2.2 and 2.3 (1/200, 1/100, 1/200, 1/
400, 1/200 respectively, Alomone Labs, Jerusalem, Israel) [46,50–
52] first for 60 min, then for 48 h at 4uC. After washing in 0.1 PB,
sections or dissociated neurons were incubated for 60 min with
biotinylated-anti-rabbit IgG (1:500, Vector Laboratories, UK),
followed by 60 min with Alexa 568-streptavidin conjugate and
anti-mouse IgG Alexa 488 (1:1000, Molecular Probes, USA). Both
primary and secondary antibodies were diluted in blocking buffer.
After further washing, sections or dissociated neurons were
mounted using a Mowiol 4–88 (Calbiochem, USA) mounting
medium, supplemented with 2.5% DABCO (Sigma). No fluores-
cent labelling was detected when primary antibodies were omitted
or incubated with a five-fold (w/v) excess of control immunogen
(provided by the antibody providers) before being exposed to the
cells or tissues. All processing was at room temperature.
To analyse cellular localisation of channel subunits in brain
slices, fluorescence signals were observed with a Leica upright
TCS-NT confocal microscope (Leica Microsystems, Heidelberg,
Germany) equipped with an Argon/Krypton laser. Using a x20
Fluotar objective with NA 0.50, each optical layer was scanned
four times, which were then averaged. Emissions from each
fluorophore were acquired consecutively to ensure no bleed-
through or cross-talk. Images were acquired using Leica Confocal
Software (Leica Microsystems, Heidelberg, Germany). Optical
sections from each SON (n= 5) in each group (adult, lactating and
PND-8) were displayed on a computer screen and analysed using
ImageJ (http://rsb.info.nih.gov/ij/). The images were converted
to 8 bit and the optical density of subunit staining was determined
by first making region-of-interest templates using staining for
either oxytocin or vasopressin, then applying these to the channel
showing the subunit staining and measuring the optical density for
the peptide and subunit within them. As different SON sections
have different numbers of oxytocin or vasopressin neurons, the
optical density of the subunit in regions of interest in different
sections was normalising by dividing by the optical density for the
peptide in that region and these values were averaged within each
treatment group.
To analyse subcellular localisation, fluorescence signals from
dissociated neurons were acquired using a Zeiss LSM510 Axiovert
confocal laser scanning microscope equipped with argon/krypton
lasers. Signals were acquired at 102461024 pixels, using a Zeiss
Plan NeoFLUAR 1.4 NA x63 oil-immersion objective. Emissions
for both fluorophores were again obtained consecutively to avoid
channel cross-talk. Images were taken throughout each cell at
Nyquist sampling rates and were deconvolved using Huygens
software (Scientific Volume Imaging) and the images examined
using NIH ImageJ software. To examine co-localisation, residual
maps were generated by calculating the residual of each voxel
VOCCs and Dendritic Peptide Release
PLoS ONE | www.plosone.org 9 October 2011 | Volume 6 | Issue 10 | e25366
from a linear regression fit of the intensity of each channel within
each voxel. The residuals ranged from 21 to 1 (pixels coloured
cyan indicate zero residual) with brightness corresponding to the
combined intensity of the two channels.
In vitro electrophysiology
SON neurons from adult female or eGFP-vasopressin rats were
acutely dissociated and plated on coverslips as described above.
The coverslips were used as the base of perfusion chambers
(Warner Instruments, Hamden, USA) mounted on an inverted
Zeiss Axioskop-2 microscope. Chambers were perfused at 1.5 ml/
min with oxygenated medium (mM: NaCl 125; CaCl2 5; HEPES/
Na 10; glucose 10; TTX 0.0002; pH 7.4; 300 mOsm; 30uC).
Patch pipettes pulled from borosilicate capillary glass had a
resistance of 4–5 MV when filled with (in mM) CsCl2 125; HEPES
10; EGTA 11; CaCl2 1: ATP-Mg 4; GTP-Tris 0.5; leupeptin 0.1;
phosphocreatin 14 and phosophocreatin kinase 0.2 mg/ml;
pH 7.2; 290–295 mOsm. Calcium currents were recorded using
a patch-clamp amplifier (Axopatch 200 B, Axon Instruments, CA,
USA) filtered at 1–2 kHz, digitised at 2–5 kHz (Digidata 1322A;
Axon Instruments), and analysed with pClamp v9 software (Axon
Instruments).
Currents evoked by a depolarisation to potentials ranging from
260 to +30 mV were normalised against the peak maximum
current evoked by a depolarisation to 210 mV. These were used
to express the mean normalised conductance (G/Gmax) at each
potential (n = 13215). The data points were fitted using the
following Boltzmann equation where V0.5 represents half-maximal
activation, k the exponential slope factor, V the membrane
potential, Vrev the reversal potential for ICa, and Gmax the
maximum whole cell conductance.
ICa Vð Þ~Gmax V{Vrevð Þ
1ze
V0:5{V
k
Statistics
Data were analysed using SigmaStatH software (Systat Software
Inc., Richmond, CA, USA) by t-tests (paired or unpaired) or, when
appropriate, by a one-way ANOVA on ranks followed by Dunn’s
or Holm-Sidak post-hoc tests. Values are expressed as mean-
s6S.E.M., and differences were considered significant when
P,0.05.
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